SWISS NORDIC BIO 2021 GOES DIGITAL
Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry. The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof. The conference is organised by the Nordic countries in cooperation with Swiss partners. Swiss Nordic Bio 2021 will be held on 10 February in digital format – the event will be live streamed and 1-to-1 meetings will be held virtually.
SWISS NORDIC BIO AT A GLANCE
Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 13 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners.
TIME AND PLACE
When: 10-11 February 2021
Where: Digial event with live stream and virutal 1-to-1 meetings.
The conference has a broad focus within biotech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.
The conference is open for biotech and pharma companies as well as investors within the life science industry. For other types of companies other conditions apply (e.g. participation fee for business services providers is 1000 EUR), please contact the Swiss-Nordic Bio organization at firstname.lastname@example.org or +43 699 1235 1519.
PARTICIPATION FEE AND REGISTRATION
General Admission Private SME Company:
EUR 600 standard price (EUR 300 subsidised fee).
At the moment SMEs from following countries are eligible for subsidised fee: Finland, Norway, Sweden and Switzerland.